TrialProstate cancer and prostatic diseases2025
Baseline serum testosterone and differential efficacy of bipolar androgen therapy and enzalutamide in the randomized TRANSFORMER trial.
Mayuko Kanayama et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.